Apellis Pharmaceuticals (APLS) Announces Proposed 7M Share Common Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Apellis Pharmaceuticals (APLS) Announces Proposed 7M Share Common Offering

Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock

January 7, 2020 4:12 PM EST

WALTHAM, Mass., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. All of the shares are being offered by Apellis. In addition, Apellis expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.

Citigroup, J.P. Morgan and Evercore ISI are acting as joint book-running managers for the offering.... More